Pictet Asset Management (Switzerland)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-219,848	Closed	-$32M	–	1642
2022 Q2	$32M	Sell	219,848 -289,186	-57%	-$36.9M	0.04%	365
2022 Q1	$60.4M	Sell	509,034 -205,989	-29%	-$25.7M	0.07%	282
2021 Q4	$98.5M	Sell	715,023 -17,701	-2%	-$2.25M	0.1%	233
2021 Q3	$102M	Buy	+732,724	New	+$91.5M	0.11%	220

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BHVN Position: Q3 2022 in Review

Pictet Asset Management (Switzerland) sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 219,848 shares — an estimated $32M sold.

Pictet Asset Management (Switzerland) first reported a position in BHVN in Q3 2021 and held it in 4 quarters. The position peaked at $102M in Q3 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Pictet Asset Management (Switzerland) reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 219,848 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $32M.
Pictet Asset Management (Switzerland) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2021 and held it in 4 quarters.
Pictet Asset Management (Switzerland)'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $102M in Q3 2021.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.